Dentons advised the offeror – Korporacja Inwestycyjna Polskiej Farmacji sp. z o.o. – with regard to the tender offer for sale of 100% shares in Pelion S.A.
The offeror is a company controlled by Mr. Jacek Szwajcowski, with Mr. Zbigniew Molenda holding a minority stake. Messrs. Szwajcowski and Molenda are both founders of Pelion. The tender offer is addressed to other shareholders of Pelion S.A.
It is the largest tender offer for shares of a company listed on the Warsaw Stock Exchange this year.
The Pelion group consists of ca. 170 subsidiaries. Services provided by the group encompass all market sectors (wholesale, retail and the hospital market) and are addressed to patients, pharmacies, hospitals and manufacturers. Pelion S.A. is a holding company exercising ownership supervision over all areas of the business of the Group, implemented accordingly by Polska Grupa Farmaceutyczną SA – wholesale, PGF Urtica – supplies for hospitals, CEPD N.V – retail sale and Pharmalink – services for manufacturers.
The Dentons team assisting the transaction was headed by Jakub Celiński, partner of Dentons Warsaw acting in cooperation with Michał Mężykowski (partner), Ryszard Manteuffel and Piotr Nerwiński (senior associates) and Lee Federman, partner of Dentons London.
Dentons is the world's largest law firm, delivering quality and value to clients around the globe. Dentons is a leader on the Acritas Global Elite Brand Index, a BTI Client Service 30 Award winner and recognized by prominent business and legal publications for its innovations in client service, including founding Nextlaw Labs and the Nextlaw Global Referral Network. Dentons' polycentric approach and world-class talent challenge the status quo to advance client interests in the communities in which we live and work. www.dentons.com